1/4

BIOTIA-ID Urine Test

Name: BIOTIA-ID Urine Test
Brand: Biotia
Price: 249.00 USD
Availability: InStock

For patients with recurrent, complicated, or culture-negative urinary tract infections

$249.00 USD $650.00 USD

*If you are not eligible for this test, the full price will be refunded.

The at-home BIOTIA-ID Urine Test is for patients with recurrent, complicated, or culture-negative UTIs with current symptoms. Biotia does not currently accept insurance for this test or the telemedicine support. This test is HSA/FSA eligible.

What's included:

At-home test kit and laboratory analysis ($239)
Eligibility review and provider communications from Clinova.Solutions ($10)
Outbound and return shipping ($48)
Optional telehealth visit with Clinova.Solutions (additional $25)

What you get:

Comprehensive report for 44 key UTI-causing pathogens, including often missed pathogens
Antibiotic resistance profiling for 4 different classes of antibiotics, using 16 marker genes, to guide treatment
End-to-end telehealth care from our partner providers

Check your eligibility

The BIOTIA-ID Urine Test is a regulated diagnostic test that requires a prescription by a licensed healthcare provider. Pre-check your eligibility below. Our telehealth partners will confirm your eligibility after account creation on the Biotia Portal.

Patients who frequently get UTIs or have persistent UTI symptoms are a good fit for this diagnostic test.

A UTI is considered recurrent if you have had 2 or more in the past 6 months, or 3 or more in the past 12 months, including your current UTI symptoms.

Pre-existing conditions and other factors may increase your risk of complications from UTIs. Some of these include:

Pregnancy
Male anatomy
Catheterization
History of urological surgery
Immunocompromised status

There are a number of conditions that may make you qualified for this test. To know for certain, purchase the test and complete your eligibility form on the Biotia Portal.

If you are not eligible, the hold on your card will be released and you will not be charged.

Urine culture is considered the standard of care to diagnose UTIs, however, it can miss as many as 1 in 3 cases (false negatives). If you have recently been tested via urine culture or another method and are still experiencing UTI symptoms, this test may be right for you.

Outperforms traditional testing

The BIOTIA-ID Urine Test has undergone rigorous analytical and clinical validation on real patient specimens and has received approval for use across all 50 U.S. states.

Some highlights include:

97% sensitivity and 99% specificity
Among patients with negative urine cultures, our test found UTI-causing pathogens in 63% of specimens (n=200). In 70% of these cases, the prescribed antibiotic would have no effect on the pathogen
Our test is particularly strong at identifying anaerobic and slow-growing pathogens as well as instances of polymicrobial infection (>3 pathogens)

Want to learn more? Click the button below to download our white paper on the BIOTIA-ID Urine Test.

Download

CLIA-CLEP Certified Laboratory

Biotia's laboratory is certified by the State of New York to conduct clinical diagnostic testing nationwide.

HIPAA Compliant Patient Portal

Our patient portal follows the strict patient privacy requirements as set forth under HIPAA.

Accountable to Our Patients

Biotia collaborates with Live UTI Free, a leading patient advocacy group for people who experience UTIs.

How it works

Purchase your test. A kit will be sent to your address provided.
Create an account and complete your eligibility form on the Biotia Portal.
Once approved, collect your sample at home.
Send your sample back to the Biotia Laboratory.
Receive a comprehensive report and follow-up care from our partner telehealth providers.

Each kit contains

Collection instructions and patient form
Biohazard bag with absorbent pad, urine collection cup, transfer pipette, and urine transport tube
Prepaid return shipping envelope

Developed with leading clinicians

Dr. Angelish Kumar, Clinical Advisor

Dr. Kumar serves as a clinical advisor for Biotia. Graduating from Tufts University School of Medicine with honors and completing residency training in urologic surgery at NYU Langone Medical Center, Dr. Kumar is a board-certified urologist with extensive experience in both private practice and hospital-based settings. Dr. Kumar's clinical focus is on the care of female patients with genitourinary issues across the lifespan. She lends her particularly strong expertise in recurrent urinary tract infections in postpartum, peri-menopausal, and post-menopausal women to guide feature development for the BIOTIA-ID Urine Test.

Trusted by patients

FAQs: The BIOTIA-ID Urine Test

A urinary tract infection (UTI) is an infection in any part of the urinary system. The urinary system includes the kidneys, ureters, bladder and urethra. Most infections involve the lower urinary tract — the bladder and the urethra.

UTIs don't always cause symptoms. When they do, they may include:

A strong urge to urinate that doesn't go away
A burning feeling when urinating
Urinating often, and passing small amounts of urine
Urine that looks cloudy
Urine that appears red, bright pink or cola-colored — signs of blood in the urine
Strong-smelling urine
Pelvic pain, particularly in women

A large number of pathogens can cause urinary tract infections. These include different kinds of bacteria and fungi.

Some people are at higher risk for UTIs, such as people with female anatomy. Additionally, certain behaviors and activities can increase a person’s risk of getting a UTI.

These include:

Previous urinary tract infection
Old age
Co-morbidities such as chronic kidney disease, cancer, and immunocompromising conditions

Risk factors specific to people with female anatomy include:

Shorter urethra as a result of female anatomy
Sexual activity
Certain types of birth control, such as diaphragms or spermicides
Pregnancy
Hormonal changes as a result of menopause

Most UTIs are diagnosed through urine culture, and in some instances, through a technique called polymerase-chain reaction (PCR). Both of these types of tests have limitations – oftentimes known UTI-causing pathogens are missed. Our test overcomes this limitation by looking at all of the pathogen DNA in your urine sample through next-generation sequencing and machine learning.

Additionally, rather than simply generating a report for your use, patients can receive follow-up care with licensed clinicians trained in UTI management.

We clinically validated this test in a CLIA-certified diagnostic laboratory using real patient specimens. We continue to participate in strict regulatory oversight for laboratory-developed tests across all 50 U.S. states. We have demonstrated a sensitivity of 97% and specificity of 99% for 44 known UTI pathogens and can detect 14 resistance marker genes for 6 different antibiotic resistance classes. This helps your provider accurately identify the pathogen(s) causing your UTI and choose an appropriate treatment.

You will receive your test kit within 1-2 days following eligibility confirmation by our partner telehealth provider. Please note that orders placed on Fridays may not be shipped out until the following Monday.

Your test kit includes a prepaid return label that ships your sample overnight directly to the Biotia Laboratory. To avoid weekend delays, we recommend that patients ship their samples Monday through Thursday. Holidays may impact return shipping. Check our website for notices of holiday closure.

Patients should ship their sample on the same day it is collected. Due to New York State regulations, samples that arrive more than 48 hours after collection cannot be accepted.

Our current days of operation are Monday-Friday. On average, results are reported within 3 business days following receipt of your sample by the Biotia Laboratory. Holidays may delay results.

You will receive notifications when your sample is received by our laboratory and when your results are ready for review.

Your results will indicate whether any of the 44 pathogens tested with BIOTIA-ID Urine were detected in your sample. If a pathogen is present and carries antibiotic resistance genes, you will receive a report that includes this information. Your clinician will review the findings and determine the most appropriate course of treatment based on the specific pathogens and any resistance genes identified.

Yes, you can discuss your test results with your own provider. We provide both our patients and our telehealth partner with a report containing your test results. You can access this report through the Biotia Patient Portal, which will allow you to download a PDF copy that you may bring to your own provider.

This test is the first-of-its-kind to receive approval as a laboratory-developed test across all 50 U.S. states. This means our test has met strict performance requirements that many wellness brands who purport to successfully diagnose you have not.

Biotia does not currently accept any insurance for the at-home collection of this test. The BIOTIA-ID Urine Test uses the latest technology in diagnostics and is the first-of-its-kind to be used on urine samples. Biotia is working with insurance companies to obtain coverage for this test.

This test is HSA/FSA eligible. Patients may choose to pay in installments during checkout.

No, the cost of prescription treatment is not included in the price of the BIOTIA-ID Urine Test. Should your provider determine you need a prescription to treat your UTI, they will send a prescription to your preferred pharmacy. You will be responsible for any costs incurred in obtaining the prescription.

The BIOTIA-ID Urine Test, including the telehealth services provided, is currently available for United States residents only. If you are an international patient, please reach out to customersupport@biotia.io to see how we might be able to help.

At-home collection for the BIOTIA-ID Urine Test is available for patients age 5 and above. Patients who are under the age of 18 are unable to place an order for this test without a parent or guardian. Please contact us at customersupport@biotia.io to discuss testing for patients under the age of 18.

Click the links to find PDF copies of the patient form and the collection instructions for at-home collection.

Stop guessing.

Start testing.

Shop now

Disclaimer: NYS LDT Approved Diagnostic Test

The BIOTIA-ID Urine NGS Assay has been approved by New York State Department of Health’s Clinical Laboratory Evaluation Program as an in vitro diagnostic laboratory developed test (LDT). This assay was developed and its performance characteristics determined by Biotia. The assay has not been cleared or approved by the FDA, nor is it required to be. The Biotia Laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA ’88) and is accredited to perform high-complexity clinical laboratory testing.